Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSTRO: Benralizumab in Severe Nasal Polyposis
NCT03401229Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2018
- Primary completion
- Jul 2020
- Modality
- Monoclonal Antibodies
- Countries
- 8
01
Overview
A Phase 3 trial of benralizumab in nasal polyposis, sponsored by AstraZeneca. Started Jan 2018; status: completed.
02
Drugs
benralizumab
03
Conditions
nasal polyposis
Beyond the preview
Go deeper on NCT03401229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03401229.